Biomarkers in Alzheimer's Disease and Lewy Body Disorders with Dementia

Biomarkers in Alzheimer's Disease and Lewy Body Disorders with Dementia

Bibliographic Details
Main Authors:	Leyhe, Thomas, Darreh-Shori, Taher, Laske, Christoph, Mielke, Michelle M., Maetzler, Walter
Format:	Online
Language:	English
Published:	Hindawi Publishing Corporation 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556405/

Similar Items

Altered Serum IgG Levels to α-Synuclein in Dementia with Lewy Bodies and Alzheimer’s Disease
by: Koehler, Niklas K. U., et al.
Published: (2013)

Neurophysiological biomarkers for Lewy body dementias
by: Cromarty, Ruth A., et al.
Published: (2016)

Lewy body disease and dementia with Lewy bodies
by: KOSAKA, Kenji
Published: (2014)

Serum and Cerebrospinal Fluid Levels of Transthyretin in Lewy Body Disorders with and without Dementia
by: Maetzler, Walter, et al.
Published: (2012)

Protein Clearance Mechanisms of Alpha-Synuclein and Amyloid-Beta in Lewy Body Disorders
by: Deleidi, Michela, et al.
Published: (2012)

Structural Connectivity is Differently Altered in Dementia with Lewy Body and Alzheimer’s Disease
by: Delli Pizzi, Stefano, et al.
Published: (2015)

Elevated Angiopoietin-1 Serum Levels in Patients with Alzheimer's Disease
by: Schreitmüller, Brigitte, et al.
Published: (2012)

Neural correlates of attention‐executive dysfunction in lewy body dementia and Alzheimer's disease
by: Firbank, Michael, et al.
Published: (2015)

Neuroimaging, Biomarkers, and Management of Dementia with Lewy Bodies
by: Hanagasi, Hasmet A., et al.
Published: (2013)

Biomarkers in biological fluids for dementia with Lewy bodies
by: Schade, Sebastian, et al.
Published: (2014)

Changes to the lateral geniculate nucleus in Alzheimer's disease but not dementia with Lewy bodies
by: Erskine, Daniel, et al.
Published: (2015)

Functional connectivity in cortical regions in dementia with Lewy bodies and Alzheimer's disease
by: Kenny, Eva R., et al.
Published: (2012)

Grey matter atrophy in prodromal stage of dementia with Lewy bodies and Alzheimer’s disease
by: Blanc, Frederic, et al.
Published: (2016)

Regional functional synchronizations in dementia with Lewy bodies and Alzheimer's disease
by: Peraza, Luis R., et al.
Published: (2016)

Multimodal EEG-MRI in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies
by: Colloby, Sean J., et al.
Published: (2016)

Random forest to differentiate dementia with Lewy bodies from Alzheimer's disease
by: Dauwan, Meenakshi, et al.
Published: (2016)

Divergent brain functional network alterations in dementia with Lewy bodies and Alzheimer's disease
by: Peraza, Luis R., et al.
Published: (2015)

Cognitive and affective theory of mind in dementia with Lewy bodies and Alzheimer’s disease
by: Heitz, Camille, et al.
Published: (2016)

The monoaminergic footprint of depression and psychosis in dementia with Lewy bodies compared to Alzheimer’s disease
by: Vermeiren, Yannick, et al.
Published: (2015)

Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia
by: Davide Chiasserini, et al.
Published: (2017-07-01)

Dementia with Lewy bodies
by: McKeith, Ian
Published: (2004)

Evaluation of annexin A5 as a biomarker for Alzheimer's disease and dementia with lewy bodies
by: Sohma, Hitoshi, et al.
Published: (2013)

Relationship between Dementia Severity and Behavioral and Psychological Symptoms of Dementia in Dementia with Lewy Bodies and Alzheimer's Disease Patients
by: Hashimoto, Mamoru, et al.
Published: (2015)

Dementia with Lewy Bodies versus Alzheimer's Disease and Parkinson's Disease Dementia: A Comparison of Cognitive Profiles
by: Park, Kyung Won, et al.
Published: (2011)

Analysis of the Substantia Innominata Volume in Patients with Parkinson’s Disease with Dementia, Dementia with Lewy Bodies, and Alzheimer’s Disease
by: Kim, Hee Jin, et al.
Published: (2011)

Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease
by: Hansson, Oskar, et al.
Published: (2014)

Exome sequencing in dementia with Lewy bodies
by: Keogh, M J, et al.
Published: (2016)

LRRK2 in Parkinson's disease and dementia with Lewy bodies
by: Zhu, Xiongwei, et al.
Published: (2006)

Disease-modifying therapeutic directions for Lewy-Body dementias
by: Zhang, Qiang, et al.
Published: (2015)

Nilotinib Effects in Parkinson’s disease and Dementia with Lewy bodies
by: Pagan, Fernando, et al.
Published: (2016)

Cortical Thickness in Dementia with Lewy Bodies and Alzheimer's Disease: A Comparison of Prodromal and Dementia Stages
by: Blanc, Frederic, et al.
Published: (2015)

Neuroimaging characteristics of dementia with Lewy bodies
by: Mak, Elijah, et al.
Published: (2014)

Comprehensive treatment of dementia with Lewy bodies
by: Boot, Brendon P
Published: (2015)

Brain perfusion in dementia with Lewy bodies and Alzheimer’s disease: an arterial spin labeling MRI study on prodromal and mild dementia stages
by: Roquet, Daniel, et al.
Published: (2016)

Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases
by: Guerreiro, Rita, et al.
Published: (2016)

α-Synuclein as CSF and Blood Biomarker of Dementia with Lewy Bodies
by: Kasuga, Kensaku, et al.
Published: (2012)

Relative survival in patients with dementia with Lewy bodies and Parkinson's disease dementia.
by: Victoria Larsson, et al.

Resting state in Parkinson's disease dementia and dementia with Lewy bodies: commonalities and differences
by: Peraza, Luis R., et al.
Published: (2015)

Plasma sphingolipid changes with autopsy-confirmed Lewy body or Alzheimer's pathology
by: Savica, Rodolfo, et al.
Published: (2016)

Novel ligands of Choline Acetyltransferase designed by in silico molecular docking, hologram QSAR and lead optimization
by: Kumar, Rajnish, et al.
Published: (2016)